EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus

Alexander I Mosa, David S Campo iD, Yury Khudyakov, Mounir G AbouHaidar iD, Adam J Gehring iD, Atif Zahoor, Jonathan K Ball, Richard A Urbanowicz iD, Jordan J Feld

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2220294120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Alexander I Mosa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Toronto Centre for Liver Disease, Toronto General Hospital, Toronto, M5G 2C4 ON, Canada. Hauptthemen laut MEDLINE: Hepacivirus, Hepatitis C. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A hepatitis C virus (HCV) vaccine is urgently needed. Vaccine development has been hindered by HCV’s genetic diversity, particularly within the immunodominant hypervariable region 1 (HVR1). Here, we developed a strategy to elicit broadly neutralizing antibodies to HVR1, which had previously been considered infeasible. We first applied a unique information theory–based measure of genetic distance to evaluate phenotypic relatedness between HVR1 variants. These distances were used to model the structure of HVR1’s sequence space, which was found to have five major clusters. Variants from each cluster were used to immunize mice individually, and as a pentavalent mixture. Sera obtained following immunization neutralized every variant in a diverse HCVpp panel (n = 10), including those resistant to monovalent immunization, and at higher mean titers (1/ID 50 = 435) than a glycoprotein E2 (1/ID 50 = 205) vaccine. This synergistic immune response offers a unique approach to overcoming antigenic variability and may be applicable to other highly mutable viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusHepatitis CAnimalsMiceViral Envelope ProteinsImmunizationImmunityHepatitis C AntibodiesAntibodies, Neutralizing

Stichwörter der Autor:innen

HVR1hepatitis c virusvaccine

Substanzen

Viral Envelope ProteinsHepatitis C AntibodiesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Toronto Centre for Liver Disease, Toronto General Hospital, Toronto, M5G 2C4 ON, Canada.
  • Molecular Epidemiology and Bioinformatics, Centers for Disease Control and Prevention, Atlanta 30333, Georgia.
  • Department of Cell and Systems Biology, University of Toronto, Toronto, M5S 3G5 ON, Canada.
  • Department of Immunology, University of Toronto, Toronto, M5S 1A8 ON, Canada.
  • Wolfson Centre for Global Virus Infections, University of Nottingham, Nottingham NG8 1BB, United Kingdom.
  • Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool CH64 7TE, United Kingdom.

ORCID-Profile: David S Campo, Mounir G AbouHaidar, Adam J Gehring, Richard A Urbanowicz

Zitieren

APA

Mosa, A. I., Campo, D. S., Khudyakov, Y., AbouHaidar, M. G., Gehring, A. J., Zahoor, A., Ball, J. K., Urbanowicz, R. A., & Feld, J. J. (2023). Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2220294120

Vancouver

Mosa AI, Campo DS, Khudyakov Y, AbouHaidar MG, Gehring AJ, Zahoor A, et al. Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2220294120

BibTeX
@article{Mosa2023,
  author = {Mosa, Alexander I and Campo, David S and Khudyakov, Yury and AbouHaidar, Mounir G and Gehring, Adam J and Zahoor, Atif and Ball, Jonathan K and Urbanowicz, Richard A and Feld, Jordan J},
  title = {Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2220294120}
}
Kostenlos starten →